Skip to main content
Premium Trial:

Request an Annual Quote

Battelle to Test IntelligentMDx's Assay for BK Virus

NEW YORK (GenomeWeb News) – The non-profit Battelle Eastern Science and Technology Center will conduct performance verification studies of IntelligentMDx’s molecular diagnostic assays, the company said today.
 
Battelle, which is headquartered in Columbus, Ohio, will perform various tests of the company’s Quantitative BK Virus Real-Time PCR Assay to identify its performance characteristics.
 
BKV is an important pathogen involved in nephrophathy in kidney transplant patients and hemorrhagic cystitis in stem cell transplant patients. The IntelligentMDx test has been developed to track the course of infection and to monitor the response to treatment.
 
Financial terms of the agreement were not released.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.